How is the Rhythm Pharmaceuticals Inc. today?

The Rhythm Pharmaceuticals Inc. today is trading in the down by -1.93% at 64.40.

How has Rhythm Pharmaceuticals Inc. performed historically?

The Rhythm Pharmaceuticals Inc. is currently trading down -1.93% on an intraday basis in the past week the index rose 8.82%. The index has been up 22.90% in the past quarter and rose 70.15% in the past year. You can view this in the overview section.

What is Rhythm Pharmaceuticals Inc. Annual Revenue?

Rhythm Pharmaceuticals Inc. Annual Revenue rose 68.06%, in the last year to $130.13 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Rhythm Pharmaceuticals Inc. Annual Net Profit?

Rhythm Pharmaceuticals Inc. Annual Net Profit fell 41.11% in the last year to $260.6 M. Its sector's average net profit growth for the last fiscal year was -13.86%.

What is Rhythm Pharmaceuticals Inc. Price to Earning Ratio?

Rhythm Pharmaceuticals Inc. Price to Earning Ratio is -24.29, which is negative.

What is Rhythm Pharmaceuticals Inc. Stock Price?

Rhythm Pharmaceuticals Inc. Stock Price rose 70.15% and outperformed its sector by 41.71% in the past year.

What is Rhythm Pharmaceuticals Inc. Quarterly Revenue?

Rhythm Pharmaceuticals Inc. Quarterly Revenue rose 25.94% YoY to $32.7 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Rhythm Pharmaceuticals Inc. Quarterly Net profit?

Rhythm Pharmaceuticals Inc. Quarterly Net profit rose 64.99% YoY to $49.5 M. Its sector's average net profit growth YoY for the quarter was -238.4%.

What is Rhythm Pharmaceuticals Inc. Debt to Equity Ratio?

Rhythm Pharmaceuticals Inc. Debt to Equity Ratio of 0.18 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Rhythm Pharmaceuticals Inc. Return on Equity(ROE)?

Rhythm Pharmaceuticals Inc. Return on Equity(ROE) for the last financial year was -276.33%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Rhythm Pharmaceuticals Inc. Mutual Fund Holding?

Rhythm Pharmaceuticals Inc. Mutual Fund Holding increased by 0.4% in the last quarter to 61.36.

What is Rhythm Pharmaceuticals Inc. Interest Coverage Ratio?

Rhythm Pharmaceuticals Inc. Interest Coverage Ratio is -11.63, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Rhythm Pharmaceuticals Inc. Institutional Holding?

Rhythm Pharmaceuticals Inc. Institutional Holding increased by 1.16% in the last quarter to 100.32.

Rhythm Pharmaceuticals Inc. XNAS: RYTM

Rhythm Pharmaceuticals Inc. Live Share Price Today, Share Analysis and Chart

Name: Rhythm Pharmaceuticals Inc.: Is Infosys Ltd. worth buying?
Item: Rhythm Pharmaceuticals Inc.
Rating: 1.4254305
Author: Trendlyne DVM scores

Momentum Trap

about

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, in...

64.40 -1.27 (-1.93%)

71.92% Gain from 52W Low

482.4K XNAS Volume

XNAS 04 Jun, 2025 5:30 PM (EDT)

Board Meeting

The board meeting for Rhythm Pharmaceuticals Inc. is scheduled for today, for the purpose of Jefferies Global Healthcare Conference See details

Low Financial Strength

22.2 / 100

Expensive Valuation

4.0 / 100

Technically Moderately Bullish

65.6 / 100

Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM

1Yr Price target upside is 30%

12 analysts

Rhythm Pharmaceuticals Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Rhythm Pharmaceuticals Inc. Live Share Price Today, Share Analysis and Chart

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, in...

71.92% Gain from 52W Low

SWOT Analysis

Rhythm Pharmaceuticals Inc. Live Price Chart

Rhythm Pharmaceuticals Inc. FAQ

How is Rhythm Pharmaceuticals Inc. today?

Rhythm Pharmaceuticals Inc. today is trading in the red, and is down by -1.93% at 64.40.

How has Rhythm Pharmaceuticals Inc. performed historically?

Rhythm Pharmaceuticals Inc. is currently trading down -1.93% on an intraday basis. In the past week the stock rose 8.82%. stock has been up 22.90% in the past quarter and rose 70.15% in the past year. You can view this in the overview section.